Selecting compounds for the chemical library is the foundation of high-throughput screening (HTS). After some years and multiple HTS campaigns, many molecules in the Novartis and NIH Molecular Libraries Program screening collections have never been found to be active. An in-depth exploration of the bioactivity of this 'dark matter' does in fact reveal some compounds of interest.
This is a preview of subscription content, access via your institution
Open Access articles citing this article.
Journal of Cheminformatics Open Access 23 July 2021
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
Prices may be subject to local taxes which are calculated during checkout
Wassermann, A.M. et al. Nat. Chem. Biol. doi:10.1038/nchembio.1936 (19 October 2015).
Polishchuk, P.G. et al. J. Comput. Aided Mol. Des. 27, 675–679 (2013).
Huggins, D.J. et al. ACS Chem. Biol. 6, 208–217 (2011).
Baell, J.B. & Holloway, G.A. J. Med. Chem. 53, 2719–2740 (2010).
Leeson, P.D. & Springthorpe, B. Nat. Rev. Drug Discov. 6, 881–890 (2007).
The author declares no competing financial interests.
About this article
Cite this article
Macarron, R. How dark is HTS dark matter?. Nat Chem Biol 11, 904–905 (2015). https://doi.org/10.1038/nchembio.1937
This article is cited by
Journal of Cheminformatics (2021)